Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fulcrum Therapeutics Inc (NQ: FULC )

3.541 +0.101 (+2.94%)
Streaming Delayed Price Updated: 11:53 AM EDT, Sep 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Fulcrum Therapeutics Inc

< Previous 1 2 3 4 5 6 Next >
Crude Oil Falls; Dick's Sporting Goods Earnings Miss Views
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling over 100 points on Tuesday. The Dow traded down 0.39% to 34,330.87 while the NASDAQ rose 0.24% to 13,530.50. The... 
Via Benzinga
Topics Earnings Stocks
Exposures Financial Fossil Fuels US Equities
Why Macy's Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) shares jumped 42.8% to $5.60 after the FDA lifted clinical hold on the company’s FTX-6058 for sickle cell disease. 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
A Preview Of Fulcrum Therapeutics's Earnings
Via Benzinga
Looking Into Fulcrum Therapeutics's Return On Capital Employed
Via Benzinga
Fulcrum Therapeutics's Earnings Outlook
Via Benzinga
Dow Falls Over 100 Points; US Existing Home Sales Decline In July
U.S. stocks traded mixed midway through trading, with the Dow Jones falling over 100 points on Tuesday. The Dow traded down 0.32% to 34,354.22 while the NASDAQ rose 0.52% to 13,567.52. The S&P 500,... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Fulcrum Therapeutics Stock Surging Today?
Fulcrum Therapeutics Inc (NASDAQ: FULC) shares are trading higher after the FDA lifted the clinical hold on the Investigational New Drug (IND) application for FTX-6058 for the potential treatment of  
Via Benzinga
Exposures Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2023
Via Benzinga
What 6 Analyst Ratings Have To Say About Fulcrum Therapeutics
Via Benzinga
Fulcrum Therapeutics, AMTD Digital, Hasbro And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded mixed, with the Dow Jones falling around 100 points on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
BLNK Stock Alert: Blink Charging Signs Deal to Bring EV Charging to McDonald’s
Blink Charging (BLNK) stock is on the move Tuesday after the EV charging company signed a deal that brings its services to McDonald's (MCD). 
Via InvestorPlace
US Stocks Mixed; Lowe's Posts Upbeat Earnings
U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining over 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.07% to 34,439.33 while the NASDAQ rose... 
Via Benzinga
Topics Stocks
Exposures US Equities
APP Stock Price Predictions: Is AppLovin Really Worth $50?
Applovin (APP) stock is in the news Tuesday after the stock got a new price target from Jefferies analyst Andrew Uerkwitz. 
Via InvestorPlace
Why Is Fulcrum Therapeutics (FULC) Stock Up 43% Today?
Fulcrum Therapeutics (FULC) stock is on the rise Tuesday after the FDA removed a clinical hold on its sickle-cell disease candidate. 
Via InvestorPlace
Exposures Product Safety
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
Via Benzinga
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2023
Via Benzinga
United Airlines To Rally Around 54%? Here Are 10 Other Analyst Forecasts For Friday
Piper Sandler raised the price target for Riskified Ltd. (NYSE: RSKD) from $6 to $8. Piper Sandler analyst Brent Bracelin upgraded the stock from Neutral to Overweight. Riskified shares rose 2.4% to... 
Via Benzinga
Why JD.com Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Dow Up 150 Points; US Weekly Jobless Claims Rise
U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Thursday. Following the market opening Thursday, the Dow traded up 0.46% to 32,948.78 while the NASDAQ rose 0.27%... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
Via Benzinga
uniQure To Rally Around 162%? Here Are 10 Other Analyst Forecasts For Tuesday
UBS cut the price target for Honeywell International Inc. (NASDAQ: HON) from $193 to $185. UBS analyst Chris Snyder maintained a Sell rating. Honeywell shares fell 0.2% to $191.99 in pre-market... 
Via Benzinga
Dow Dips 350 Points; S&P 500 Down Over 1%
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 300 points on Friday. The Dow traded down 1.07% to 32,798.91 while the NASDAQ fell 1.90% to 11,370.53. The S&P 500... 
Via Benzinga
Stocks Extend Slump, Head For Weekly Losses
Stocks are extending their premarket losses, with the Dow Jones Industrial Average down 409 points. 
Via Talk Markets
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Fulcrum Therapeutics Shares Are Trading Lower By Over 55%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Bridger Aerospace Group Holdings, Inc. (NASDAQ: BAER) shares jumped 129.6% to $10.15. Jeffrey E. Kelter reported a 22.4% stake in a 13D filing on Thursday. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.